Targeting SLC7A11 to induce ferroptosis could have important translational value in CRC treatment since our results demonstrated that low expression of uL3 and high levels of SLC7A11 were associated with a poor outcome in patients with CRC (Figure 3d). Here, SLC7A11 is linked to colorectal carcinoma.